Mechanism of action of trastuzumab and scientific update

被引:78
作者
Baselga, J [1 ]
Albanell, J [1 ]
Molina, MA [1 ]
Arribas, J [1 ]
机构
[1] Univ Barcelona, Hosp Gen Valle Hebron, Med Oncol Serv, Barcelona 08035, Spain
关键词
D O I
10.1016/S0093-7754(01)90276-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4 / 11
页数:8
相关论文
共 32 条
  • [1] THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN
    BARGMANN, CI
    HUNG, MC
    WEINBERG, RA
    [J]. NATURE, 1986, 319 (6050) : 226 - 230
  • [2] Baselga J, 1999, SEMIN ONCOL, V26, P78
  • [3] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast
    Baselga, J
    Tripathy, D
    Mendelsohn, J
    Baughman, S
    Benz, CC
    Dantis, L
    Sklarin, NT
    Seidman, AD
    Hudis, CA
    Moore, J
    Rosen, PP
    Twaddell, T
    Henderson, IC
    Norton, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 737 - 744
  • [4] Brodowicz T, 1997, INT J CANCER, V73, P875, DOI 10.1002/(SICI)1097-0215(19971210)73:6<875::AID-IJC19>3.0.CO
  • [5] 2-3
  • [6] HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY
    CARTER, P
    PRESTA, L
    GORMAN, CM
    RIDGWAY, JBB
    HENNER, D
    WONG, WLT
    ROWLAND, AM
    KOTTS, C
    CARVER, ME
    SHEPARD, HM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4285 - 4289
  • [7] Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
    Clynes, RA
    Towers, TL
    Presta, LG
    Ravetch, JV
    [J]. NATURE MEDICINE, 2000, 6 (04) : 443 - 446
  • [8] CONDONYSERVAT J, 1999, CANCER RES, V59, P1196
  • [9] TYROSINE KINASE RECEPTOR WITH EXTENSIVE HOMOLOGY TO EGF RECEPTOR SHARES CHROMOSOMAL LOCATION WITH NEU ONCOGENE
    COUSSENS, L
    YANGFENG, TL
    LIAO, YC
    CHEN, E
    GRAY, A
    MCGRATH, J
    SEEBURG, PH
    LIBERMANN, TA
    SCHLESSINGER, J
    FRANCKE, U
    LEVINSON, A
    ULLRICH, A
    [J]. SCIENCE, 1985, 230 (4730) : 1132 - 1139
  • [10] ERBB-2 IS A POTENT ONCOGENE WHEN OVEREXPRESSED IN NIH/3T3 CELLS
    DIFIORE, PP
    PIERCE, JH
    KRAUS, MH
    SEGATTO, O
    KING, CR
    AARONSON, SA
    [J]. SCIENCE, 1987, 237 (4811) : 178 - 182